Interaction of the lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis

American Journal of Pathology

Volumn 173, Issue 5, 2008, Pages 1415-1427

  Ramesh, Geeta ^a   Borda, Juan T ^a   Dufour, Jason ^a   Kaushal, Deepak ^a   Ramamoorthy, Ramesh ^a   Lackner, Andrew A ^a   Philipp, Mario T ^a  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL13 CHEMOKINE; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; BORRELIA BURGDORFERI; BRAIN CORTEX; BRAIN TISSUE; CENTRAL NERVOUS SYSTEM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE RELEASE; DNA MICROARRAY; EX VIVO STUDY; FEMALE; GENE FUNCTION; GENETIC TRANSCRIPTION; GLIA CELL; IMMUNOFLUORESCENCE TEST; IN VIVO STUDY; INFLAMMATION; INOCULATION; LYME DISEASE; MACACA; MALE; MEDIATOR RELEASE; MICROARRAY ANALYSIS; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SPIROCHETE; STEREOTACTIC PROCEDURE;

EID: 55349148039     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2008.080483     Document Type: Article

References (76)

1. Steere AC, Grodzicki RL, Kornblatt AN, Craft JE, Barbour AG, Burgdorfer W, Schmid GP, Johnson E, Malawista SE: The spirochetal etiology of Lyme disease. N Engl J Med 1983, 308:733-740
2. Piesman J: Dynamics of Borrelia burgdoferi transmission by Ixodes dammini ticks. J Infect Dis 1993, 167:1082-1085
3. Steere AC: Lyme disease. N Engl J Med 2001, 345:115-125
4. Gustaw K, Beltowska K, Studzinska MM: Neurological and psychological symptoms after severe acute neuroborreliosis. Ann Agric Environ Med 2001, 8:91-94
5. Jacobi C, Schwark C, Kress B, Hug A, Storch-Hagenlocher B, Schwaninger M: Subarachnoid hemorrhage due to Borrelia burgdorferi-associated vasculitis. Eur J Neurol 2006, 13:536-538
6. Chehrenama M, Zagardo MT, Koski CL: Subarachnoid hemorrhage in a patient with Lyme disease. Neurology 1997, 48:520-523
7. Schmitt AB, Küker W, Nacimiento W: Neuroborreliosis with extensive cerebral vasculitis and multiple cerebral infarcts. Nervenarzt 1999, 70:167-171
8. Seijo Martínez M, Grandes Ibáñez J, García-Monocó JC: Spontaneous brain hemorrhage associated with Lyme neuroborreliosis. Neurologia 2001, 16:43-45
9. Kohler J: Lyme borreliosis: a case of transverse myelitis with syrinx cavity. Neurology 1989, 39:1553-1554
10. Benach JL, Garcia-Monoco JC: Aspects of the pathogenesis of neuroborreliosis. Lyme Disease: Molecular and Immunological Approaches. Edited by Schutzer S. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1992, pp. 1-10
11. Oksi J, Kalimo H, Marttila RJ, Marjamaki M, Sonninen P, Nikoskelainen J, Viljanen MK: Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. Brain 1996, 119:2143-2154
12. Dryden MS, O'Connell S, Samuel W, Iannotti F: Lyme myelitis mimicking neurological malignancy. Lancet 1996, 348:624
13. Benveniste EN: Inflammatory cytokines within the central nervous system: sources, functions, and mechanisms of action. Am J Physiol 1992, 263:C1-C5
14. Merrill JE, Benveniste EN: Cytokines in inflammatory brain lesions: helpful and harmful. TINS 1996, 19:331-338
15. Rothwell NJ, Hopkins SJ: Cytokines and nervous system II: actions and mechanisms of action. Trends Neurosci 1995, 18:130-136
16. Raivich G, Jones LL, Werner A, Bluthmann, Doetschmann T, Kreutzberg GW: Molecular signals for glial activation: pro- and antiinflammatory cytokines in the injured brain. Acta Neurochir Suppl 1999, 73:21-30
17. Wang WZ, Fredrikson S, Sun JB, Link H: Lyme neuroborreliosis: evidence for persistent up-regulation of Borrelia burgorferi-reactive cells secreting interferon-gamma. Scand J Immunol 1995, 42:694-700
18. Ekerfelt C, Jarefors S, Tynngard N, Hedlund M, Sander B, Bergstrom S, Forsberg P, Ernerudh J: Phenotypes indicating cytolytic properties of Borrelia-specific interferon-γ secreting cells on chronic Lyme neuroborreliosis. J Neuroimmunol 2003, 145:115-126
19. Kondrusik M, Sweirzbinska R, Pancewicz S, Zajkowska J, Grygorczuk S, Hermanowska-Szpakowicz T: Evaluation of proinflammatory cytokine (TNF-alpha, IL-1beta, IL-6, IFN-gamma) concentrations in serum and cerebrospinal fluid of patients with neuroborreliosis. Neurol Neurochir Pol 2004, 38:265-270
20. Widhe M, Grusell M, Ekerfelt C, Vrethem M, Forsberg P, Ernerudh J: Cytokines in Lyme borreliosis: lack of early tumor necrosis factor-α and transforming growth factor-β1 responses are associated with chronic neuroborreliosis. Immunology 2002, 107:46-55
21. Rupprecht TA, Pfister HW, Angele B, Kastenbauer S, Wilske B, Koedel U: The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurology 2005, 65:448-450
22. Grygorczuk S, Pancewicz S, Zajkowska J, Kondrusik M, Swierzbinska R, Hermanowska-Szpakowicz T: Concentration of macrophage inflammatory proteins MIP-α and MIP-β and interleukin 8 (IL-8) in Lyme borreliosis. Infection 2004, 32:350-355
23. Grygorczuk S, Zajkowska J, Swierzbinska R, Pancewicz S, Kondrusik M, Hermanowska-Szpakowicz T: Concentration of interferon-inducible T cell chemoattractant and monocyte chemotactic protein-1 with Lyme borreliosis. Ann Acad Med Bialo 2005, 50:173-178
24. Lewczuk P, Reiber H, Korenke GC, Bollensen E, Dorta-Contreras AJ: Intrathecal release of sICAM-1 into CSF in neuroborreliosis increased brain-derived fraction. J Neuroimmunol 2000, 103:93-96
25. Philipp MT, Aydintug MK, Bohm Jr RP, Cogswell FB, Dennis VA, Lanners HN, Lowrie Jr RC, Roberts ED, Conway MD, Karacorlu M, Peyman GA, Gubler DJ, Johnson BJB, Piesman J, Gu Y: Early and early-disseminated phases of Lyme disease in the rhesus monkey: a model of infection in humans. Infect Immun 1993, 61:3047-3059
26. Roberts ED, Bohm Jr RP, Cogswell FB, Lanners HN, Lowrie Jr RC, Povinelli L, Piesman J, Philipp MT: Chronic Lyme disease in the rhesus monkey. Lab Invest 1995, 72:146-160
27. Pachner AR, Delaney E, O'Neil T, Major E: Inoculation of non human primates with the N40 strain of Borrelia burgdorferi leads to a model of Lyme neuroborreliosis faithful to the human disease. Neurology 1995, 45:165-172
28. England JD, Bohm Jr R, Roberts ED, Philipp MT: Mononeuropathy multiplex in rhesus monkeys with chronic Lyme disease. Ann Neurol 1997, 41:375-384
29. Roberts ED, Bohm Jr RP, Lowrie Jr RC, Habicht G, Katona L, Piesman J, Philipp MT: Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system. J Infect Dis 1998, 178:722-732
30. Cadavid D, O'Neil T, Schaefer H, Pachner AR: Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of Lyme disease. Lab Invest 2000, 80:1043-1054
31. Pachner AR: The rhesus model of Lyme neuroborreliosis. Immunol Rev 2001, 183:186-204
32. Bai Y, Narayan K, Dail D, Sondey M, Hodzic E, Barthold SW, Pachner AR, Cadavid D: Spinal cord involvement in the nonhuman primate model of Lyme disease. Lab Invest 2004, 84:160-172
33. Haber SN: The primate basal ganglia: a parallel and integrative networks. J Chem Neuroanat 2003, 26:317-330
34. Jackson CL: Brefeldin A revealing fundamental principles governing membrane dynamics and protein transport. Subcell Biochem 2000, 34:233-272
35. Ramamoorthy R, McClain NA, Gautum A, Scholl-Meeker D: Expression of the bmpB gene of Borelia burgdorferi is modulated by two distinct transcription termination events. J Bacteriol 2005, 187:2592-2600
36. Kaushal D, Naeve CW: Analyzing and visualizing expression data with Spotfire. Current Protocols in Bioinformatics. Edited by Baxevanis A. Hoboken, John Wiley and Sons Inc. 2004, pp 7.9.1-7.9.25
37. Ramesh G, Alvarez X, Borda JT, Aye PP, Lackner AA, Sestak K: Visualizing cytokine-secreting cells in situ in the rhesus macaque model of chronic gut inflammation. Clin Diag Lab Immunol 2005, 12:192-197
38. Schmidt-Kastner R, Szymas J: Immunohistochemistry of glial fibrillary acid protein, vimentin and S-100 protein for study of astrocytes in hippocampus of rat. J Chem Neuroanat 1990, 3:179-192
39. Minghetti L: Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 2004, 63:901-910
40. Pachner AR, Amemiya K, Delaney E, O'Neil T, Hughes CAN, Zhang WF: Interleukin-6 is expressed at high levels in the CNS in Lyme neuroborreliosis. Neurology 1997, 49:147-152
41. Chiang CS, Stalder A, Campbell IL: Reactive gliosis as a consequence of interleukin 6 expression in the brain: studies in transgenic mice. Dev Neurosci 1994, 16:212-221
42. Dotevall L, Hagberg L, Karlsson JL, Rosengren LE: Astroglial and neuronal proteins in cerebrospinal fluid as markers of CNS involvement in Lyme neuroborreliosis. Eur J Neurol 1999, 6:169-178
43. Dotevall L, Rosengren LE, Hagberg L: Increased cerebrospinal fluid levels of glial fibrillary acidic protein (GFAP) in Lyme neuroborreliosis. Infection 1996, 24:125-129
44. Ramesh G, Alvarez AL, Roberts ED, Dennis VA, Lasater BL, Alvarez X, Philipp MT: Pathogenesis of Lyme neuroborreliosis: Borrelia burgdorferi lipoproteins induce both proliferation and apoptosis in rhesus monkey astrocytes. Eur J Immunol 2003, 33:2539-2550
45. Habicht GS, Katona LI, Benach JL: Cytokines and the pathogenesis of neuroborreliosis: Borrelia burgdorferi induces glioma cells to secrete interleukin-6. J Infect Dis 1991, 164:568-574
46. Ramesh G: An in vitro model of the interaction of bacterial lipoproteins with the central nervous system (Ph.D. thesis). [New Orleans (LA)]Tulane University
47. Piecyk M, Wax S, Beck AR, Kedersha N, Gupta M, Maritim B, Chen S, Gueydan C, Kruys V, Streuli M, Anderson P: TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. EMBO J 2000, 19:4154-4163
48. Friedman WJ: Interactions of interleukin-1 with neurotropic factors in the central nervous system: beneficial or detrimental? Mol Neurobiol 2005, 32:133-144
49. Srinivasan D, Yen JH, Joseph DJ, Friedman W: Cell type-specific interleukin-1beta signaling in the CNS. J Neurosci 2004, 24:6482-6488
50. Friedman WJ: Cytokines regulate expression of the type 1 interleukin-1 receptor in rat hippocampal neurons and glia. Exp Neurol 2001, 168:23-31
51. Zeise ML, Madamba S, Siggins GR: Interleukin-1β increases synaptic inhibition in rat hippocampal pyramidal neurons in vitro. Regul Pept 1992, 39:1-7
52. Katsuki H, Nakai S, Hirai Y, Akaji K, Kiso Y, Satoh M: Interleukin-1β inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur J Pharmacol 1990, 181:323-326
53. Ma XC, Gottschall PE, Chen LT, Wiranowska M, Phelphs CP: Role and mechanisms of interleukin-1 in the modulation of neurotoxicity. Neuroimmunomodulation 2002-2003, 10:199-207
54. Griffin WS: Inflammation and neurodegenerative diseases. Am J Clin Nutr 2006, 83:470S-474S
55. Pachner AR, Dail D, Narayan K, Dutta K, Cadavid D: Increased expression of B-lymphocyte chemoattractant, but not pro-inflammatory cytokines, in muscle tissue in rhesus chronic Lyme borreliosis. Cytokine 2002, 19:297-307
56. Narayan K, Dail D, Li L, Cadavid D, Amrute S, Fitzgerald-Bocaesly P, Pachner AR: The nervous system as ectopic germinal center: CXCL13 and IgG in Lyme neuroborreliosis. Ann Neurol 2005, 57:813-823
57. Cadavid D: The mammalian host response to borrelia infection. Wien Klin Wochenschr 2006, 18:653-658
58. Rupprecht TA, Kirschning CJ, Popp B, Kastenbauer S, Fingerle V, Pfister HW, Koedel U: Borrelia garinii induces CXCL13 production in human monocytes through Toll-like receptor 2. Infect Immun 2007, 75:4351-4356
59. Fraser CM, Casjens S, Huang WM, Sutton GG, Clayton R, Lathigra R, White O, Ketchum KA, Dodson R, Hickey EK, Gwinn M, Dougherty B, Tomb JF, Fleischmann RD, Richardson D, Peterson J, Kerlavage AR, Quackenbush J, Salzberg S, Hanson M, van Vugt R, Palmer N, Adams MD, Gocayne J, Weidman J, Utterback T, Watthey L, McDonald L, Artiach P, Bowman C, Garland S, Fuji C, Cotton MD, Horst K, Roberts K, Hatch B, Smith HO, Venter JC: Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 1997, 390:580-586
60. Casjens S, Palmer N, van Vugt R, Huang WM, Stevenson B, Rosa P, Lathigra R, Sutton G, Peterson J, Dodson RJ, Haft D, Hickey E, Gwinn M, White O, Fraser CM: A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol 2000, 35:490-516
61. Carlson NG, Hill KE, Tsunoda I, Fujinami RS, Rose JW: The pathogenic role for COX-2 in apoptotic oligodendrocytes in virus induced demyelinating disease: implications for multiple sclerosis. J Neuroimmunol 2006, 174:21-31
62. Cernak I, O'Connor C, Vink R: Activation of cyclooxygenase-2 contributes to motor and cognitive dysfunction following diffuse traumatic brain injury in rats. Clin Exp Pharmacol Physiol 2001, 28:922-925
63. Ma W, Quirion R: Up-regulation of interleukin-6 induced by prostaglandin E from invading macrophages following nerve injury: an in vivo and in vitro study. J Neurochem 2005, 93:664-673
64. Rasley A, Anguita J, Marriot I: Borrelia burgdorferi induces inflammatory mediator production of murine microglia. J Neuroimmunol 2002, 130:22-31
65. Dickson DW, Lee SC, Mattiace LA, Yen SC, Brosnan C: Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 1993, 7:75-83
66. Nagatsu T, Sawada M: Inflammatory process in Parkinson's disease: role for cytokines. Curr Pharm Des 2005, 11:999-1016
67. Orandle MT, MacLean AG, Sasseville VG, Alvarez X, Lackner AA: Enhanced expression of proinflammatory cytokines in the central nervous system is associated with neuroinvasion by simian immunodeficiency virus and the development of encephalitis. J Virol 2002, 76:5797-5802
68. Adamson DC, Dawson TM, Zink MC, Clements JE, Dawson VL: Neurovirulent simian immunodeficiency virus infection induces neuronal, endothelial and glial apoptosis. Mol Med 1996, 2:417-428
69. Cruz AR, Moore MW, La Vake CJ, Eggers CH, Salazar JC, Radolf JD: Phagocytosis of B. burgdorferi potentiates innate immune activation and induces apoptosis in human monocytes. Infect Immun 2008, 76:56-70
70. Takahashi JL, Giuliani F, Powe C, Imai Y, Young VW: Interleukin-beta promotes oligodendrocyte death through glutamate excitotoxicity. Ann Neurol 2003, 53:588-595
71. Compston A Zajicek J, Sussman J, Webb A, Hall G, Muir D, Shaw C, Wood A, Scolding N: Glial lineages and myelination in the central nervous system. J Anat 1997, 190:161-200
72. Namura S, Zhu J, Fink K, Endres M, Srinivasan A, Tomaselli KJ, Yuan J, Moskowitz MA: Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci 1998, 18:3659-3668
73. de Torres C, Munell F, Ferrer I, Reventos J, Macaya A: Identification of necrotic cell death by the TUNEL assay in the hypoxic ischemic neonatal rat brain. Neurosci Lett 1997, 230:1-4
74. Maderna P, Godson C: Phagocytosis of apoptotic cells and resolution of inflammation. Biochem Biophys Acta 2003, 1639:141-151
75. Chaparro-Huerta V, Rivera-Cervantes MC, Flores-Soto ME, Gomez-Pinedo U, Beas-Zarate C: Proinflammatory cytokines and apoptosis following glutamate-induced excitotoxicity mediated by p38 MAPK in the hippocampus of neonatal rats. J Neuroimmunol 2005, 165:53-62
76. Ramesh G, Philipp MT: Pathogenesis of Lyme neuroborreliosis: mitogen-activated protein kinases Erk1, Erk2, and p38 in the response of astrocytes to Borrelia burgdorferi lipoproteins. Neurosci Lett 2005, 384:112-116